Page last updated: 2024-09-03

efonidipine and bucladesine

efonidipine has been researched along with bucladesine in 1 studies

Compound Research Comparison

Studies (efonidipine)	Trials (efonidipine)	Recent Studies (post-2010) (efonidipine)	Studies (bucladesine)	Trials (bucladesine)	Recent Studies (post-2010) (bucladesine)
129	18	30	9,775	13	210

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ikeda, K; Saito, T; Tojo, K	1

Other Studies

1 other study(ies) available for efonidipine and bucladesine

Article	Year
Efonidipine, a Ca(2+)-channel blocker, enhances the production of dehydroepiandrosterone sulfate in NCI-H295R human adrenocortical carcinoma cells. The Tohoku journal of experimental medicine, 2011, Volume: 224, Issue:4 Topics: Adrenocortical Carcinoma; Angiotensin II; Bucladesine; Calcium Channel Blockers; Cell Line, Tumor; Dehydroepiandrosterone Sulfate; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Hydrocortisone; Nitrophenols; Organophosphorus Compounds; Phosphoproteins; RNA, Messenger; Verapamil	2011

Article

Year

Efonidipine, a Ca(2+)-channel blocker, enhances the production of dehydroepiandrosterone sulfate in NCI-H295R human adrenocortical carcinoma cells.

The Tohoku journal of experimental medicine, 2011, Volume: 224, Issue:4

Topics: Adrenocortical Carcinoma; Angiotensin II; Bucladesine; Calcium Channel Blockers; Cell Line, Tumor; Dehydroepiandrosterone Sulfate; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Hydrocortisone; Nitrophenols; Organophosphorus Compounds; Phosphoproteins; RNA, Messenger; Verapamil

2011